Ascorbate modulation of H2O2 and camptothecin-induced cell death in Jurkat cells

Cancer Chemotherapy and Pharmacology

Volumn 54, Issue 4, 2004, Pages 315-321

  Sané, Alain Théophile ^a   Cantin, André M ^b   Paquette, Benoit ^c   Wagner, J Richard ^a,c  

^a UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Dehydroascorbate; Reactive oxygen species; Topoisomerase inhibitors

Indexed keywords

ASCORBIC ACID; CAMPTOTHECIN; DEHYDROASCORBIC ACID; HYDROGEN PEROXIDE;

APOPTOSIS; ARTICLE; CANCER THERAPY; CELL DEATH; CELL LYSATE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

ASCORBIC ACID; CAMPTOTHECIN; CELL DEATH; DEHYDROASCORBIC ACID; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; HUMANS; HYDROGEN PEROXIDE; JURKAT CELLS; TIME FACTORS;

EID: 4644248243     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-004-0828-8     Document Type: Article

References (42)

1. Agus DB, Vera JC, Golde DW (1999) Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res 59:4555-4558
2. 2 induce apoptosis through fenton chemistry independent of the cellular thiol state. Free Radic Biol Med 30:1008-1018
3. Asano K, Satoh K, Hosaka M, Arakawa H, Inagaki M, Hisamitsu T, Maeda M, Kochi M, Sakagami H (1999) Production of hydrogen peroxide in cancerous tissue by intravenous administration of sodium 5,6-benzylidene-L-ascorbate. Anticancer Res 19:229-236
4. Bachleitner-Hofmann T, Gisslinger B, Grumbeck E, Gisslinger H (2001) Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia? Br J Haematol 112:783-786
5. 2. Free Radic Biol Med 33:691-702
6. Bijur GN, Briggs B, Hitchcock CL, Williams MV (1999) Ascorbic acid-dehydroascorbate induces cell cycle arrest at G2/M DNA damage checkpoint during oxidative stress. Environ Mol Mutagen 33:144-152
7. Cameron E, Campbell A (1974) The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 9:285-315
8. Casciari JJ, Riordan NH, Schmidt TL, Meng XL, Jackson JA, Riordan HD (2001) Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. Br J Cancer 84:1544-1550
9. Chandra J, Samali A, Orrenius S (2000) Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29:323-333
10. Chau YP, Shiah SG, Don MJ, Kuo ML (1998) Involvement of hydrogen peroxide in topoisomerase inhibitor beta-lapachone-induced apoptosis and differentiation in human leukemia cells. Free Radic Biol Med 24:660-670
11. Clement MV, Ramalingam J, Long LH, Halliwell B (2001) The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide. Antiox Red Sign 3:157-163
12. Crott JW, Fenech M (1999) Effect of vitamin C supplementation on chromosome damage, apoptosis and necrosis ex vivo. Carcinogenesis 20:1035-1041
13. Guaiquil VH, Farber CM, Golde DW, Vera JC (1997) Efficient transport and accumulation of vitamin C in HL-60 cells depleted of glutathione. J Biol Chem 272:9915-9921
14. Guaiquil VH, Vera JC, Golde DW (2001) Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells. J Biol Chem 276:40955-40961
15. Hampton MB, Orrenius S (1997) Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett 414:552-556
16. Hoffer LJ (2001) Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies. Can Med Assoc J 164:351-353
17. Hussein MA (2001) Arsenic trioxide - a new immunomodulatory agent in the management of multiple myeloma. Med Oncol 18:239-242
18. Kang JS, Cho DH, Kim YI, Hahm E, Yang YH, Kim D, Hur D, Park H, Bang S, Hwang YI, Lee WJ (2003) L-ascorbic acid (vitamin C) induces the apoptosis of B16 murine melanoma cells via a caspase-8-independent pathway. Cancer Immunol Immunother 52:693-698
19. Kaufmann SH (1998) Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim Biophys Acta 1400:195-211
20. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415-1420
21. Lee YJ, Shacter E (2000) Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo. Free Radic Biol Med 29:684-692
22. Lee SH, Yoon YC, Jang YY, Song JH, Han ES, Lee CS (2001) Effect of iron and ascorbate on cyclosporine-induced oxidative damage of kidney mitochondria and microsomes. Pharmacol Res 43:161-171
23. Lenton KJ, Therriault H, Fulop T, Fayette H, Wagner JR (1999) Glutathione and ascorbate are negatively correlated with oxidative DNA damage in human lymphocytes. Carcinogenesis 20:607-613
24. Mizutani H, Tada-Oikawa S, Hiraku Y, Oikawa S, Kojima M, Kawanishi S (2002) Mechanism of apoptosis induced by a new topoisomerase inhibitor through the generation of hydrogen peroxide. J Biol Chem 277:30684-30689
25. Padayatty SJ, Levine M (2001) New insights into the physiology and pharmacology of vitamin C. Can Med Assoc J 164:353-355
26. Puskas F, Gergely P, Banki K, Perl A (2000) Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. Fed Am Soc Exp Biol J 14:1352-1361
27. Ricci JE, Gottlieb RA, Green DR (2003) Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J Cell Biol 160:65-75
28. Rose RC, Bode AM (1995) Analysis of water-soluble antioxidants by high-pressure liquid chromatography. Biochem J 306:101-105
29. Sakagami H, Satoh K (1997) Modulating factors of radical intensity and cytotoxic activity of ascorbate. Anticancer Res 17:3513-3520
30. Sakagami H, Satoh K, Hakeda Y, Kumegawa M (2000) Apoptosis-inducing activity of vitamin C and vitamin K. Cell Mol Biol 46:129-143
31. Sane AT, Bertrand R (1998) Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities. Cancer Res 58:3066-3072
32. Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG (1985) Glutathione cycle activity and pyridine nucleotide levels in oxidant-induced injury of cells. J Clin Invest 76:1131-1139
33. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, Cochrane CG (1986) Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 83:4908-4912
34. 2. Free Radic Biol Med 34:521-530
35. Shiah SG, Chuang SE, Chau YP, Shen SC, Kuo ML (1999) Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone induced apoptosis through an oxidation-dependent pathway. Cancer Res 59:391-398
36. Song JH, Shin SH, Wang W, Ross GM (2001) Involvement of oxidative stress in ascorbate-induced proapoptotic death of PC12 cells. Exp Neurol 169:425-437
37. Spielholz C, Golde DW, Houghton AN, Nualart F, Vera JC (1997) Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells. Cancer Res 57:2529-2537
38. Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51:794-798
39. Taper HS, de Gerlache J, Lans M, Roberfroid M (1987) Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment. Int J Cancer 40:575-579
40. Verrax J, Cadrobbi J, Delvaux M, Jamison JM, Gilloteaux J, Summers JL, Taper HS, Calderon PB (2003) The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy. Eur J Med Chem 38:451-457
41. Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J (1996) Wide expression of the human erythrocyte glucose transporter GLUT1 in human cancers. Cancer Res 56:1164-1167
42. Younes M, Juarez D, Lechago LV, Lerner SP (2001) GLUT 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Anticancer Res 21:575-578